Elekta has won a major financing tender where the Health Department of the People’s Liberation Army is expanding its capacity to treat cancer.
Elekta will deliver a comprehensive range of clinical solutions, including Leksell Gamma Knife as well as linear accelerators and associated software.
The total value of the financing amounts to some USD 35 million, making it Elekta’s largest deal ever in China. The order will be booked when all conditions in the tender have been finalized.
For further deal information visit Current Agreements (subscription required)
Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Financing Scorecard – view top life science financing deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard– latest trends in big pharma deal making activity